Abstract:Background Non-coding RNAs (ncRNAs), including small nucleolar RNAs (snoRNAs), are widely involved in the physiological and pathological processes of human beings. While up to date, although considerable progress has been achieved in ncRNA-related pathogenesis of non-small cell lung cancer (NSCLC), the underlying mechanisms and biological significance of snoRNAs in NSCLC still need to be further clarified. Methods Quantitative real-time polymerase chain reaction or RNAscope was performed to verify the expression of Small Nucleolar RNA, H/ACA Box 38B (SNORA38B) in NSCLC cell lines or clinical samples. BALB/c nude mice xenograft model or C57BL/6J mice syngeneic tumor model were estimated to detect the effects of SNORA38B in tumor growth or tumor immune microenvironment in vivo. Cytometry by time of flight, enzyme-linked immunosorbent assay and flow cytometry assay were conducted to clarify the effects and mechanisms of SNORA38B-mediated tumor immunosuppressive microenvironment. The binding activity between SNORA38B and E2F transcription factor 1(E2F1) was detected by RNA immunoprecipitation and RNA pull-down assays. Then, bioinformatics analysis and chromatin immunoprecipitation were utilized to demonstrate the regulation of GRB2-associated-binding protein 2 (GAB2) by E2F1. Moreover, the combinatorial treatment of SNORA38B locked nucleic acid (LNA) and immune checkpoint blockade (ICB) was used to treat murine Lewis lung carcinoma-derived tumor burden C57BL/6J mice to clarify the effectiveness of targeting SNORA38B in NSCLC immunotherapy. Results SNORA38B was found highly expressed in NSCLC tissues and cell lines, and associated with worse prognosis. Further results showed that SNORA38B functioned as an oncogene via facilitating cell proliferation, migration, invasion, and inhibiting cell apoptosis in vitro and promoting tumorigenesis of NSCLC cells in vivo. SNORA38B could also recruit the CD4 + FOXP3 + regulatory T cells by triggering tumor cells to secrete interleukin 10, which in turn reduced the infiltration of CD3 + CD8 + T cells in NSCLC tumor microenvironment (TME), favoring tumor progression and poorer immune efficacy. Mechanistically, SNORA38B mainly distributed in the nucleus, and promoted NSCLC progression by regulating GAB2 transcription to activate protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway through directly binding with E2F1. Moreover, we found that SNORA38B LNAs were able to ameliorate CD3 + CD8 + T cell infiltration in TME, which sensitized NSCLC to the treatment of ICB. Conclusions In conclusion, our data demonstrated that SNORA38B functioned as an oncogene in NSCLC both in vitro and in vivo at least in part by regulating the GAB2/AKT/mTOR pathway via directly binding to E2F1. SNORA38B could also sensitize NSCLC to immunotherapy, which may be a critical therapeutic target for NSCLC.

The Impact of Nucleostemin siRNA on the Proliferation of HepG2 Cells

siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell

Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis.

BC047440 Gene Silencing Inhibits the Proliferation of HepG2 Cells

[Influence of RNA Interference on MSI-2 Gene in THP-1 Cell and Expression of NUMB].

Knockdown of Nucleostemin in an Ovarian Cancer SKOV-3 Cell Line and Its Effects on Cell Malignancy

In Vitro Enhancement of Radiation-Induced Apoptosis in Human Hepatoma Cell Line HepG2 by a Selective Inhibitor of Cyclooxygenase-2 Enzyme NS -398

Silencing of the S-Phase Kinase-Associated Protein 2 Gene (SKP2) Inhibits Proliferation and Migration of Hepatocellular Carcinoma Cells

[Effects of Inhibiting Nucleosomal Binding Protein 1 on Proliferation of Human Prostate Cancer Cells].

Effects of NANOG Expression on Proliferation and Cell Cycle of Acute Lymphoblastic Leukemia Cells

Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation

Effects of inhibiting nucleosomal binding protein 1 on proliferation of human bladder cancer cells

Effects of RNA Interference Polo-Like Kinase-1 Gene on Telomerase Activity of Human Colon Cancer Cell

Knockdown of STIM1 Expression Inhibits Non-Small-cell Lung Cancer Cell Proliferation in Vitro and in Nude Mouse Xenografts.

The effects of stathmin on cell proliferation and tumor-related genes expressions in HCCLM3 cells

The Studies on Effect of Survivin siRNA for Apoptosis,Proliferation and Invasion of Colon Carcinoma Cell Line

RNA interference-mediated knockdown of p21 promotes cell proliferation in human hepatocellular carcinoma cell line SMMC-7721

Overexpression of NOP58 Facilitates Proliferation, Migration, Invasion, and Stemness of Non-small Cell Lung Cancer by Stabilizing hsa_circ_0001550

Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.

Significance of Sirna-Mediated TGFBR2 Gene Silencing on HepG2 Cell Proliferation

Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway